Characterization of TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in women
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210289
- Recipient
-
Mayo Clinic Jacksonville (A Nonprofit Corporation) UEI GKPBCFV1QMM3 Part of Mayo Clinic
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $874,988
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Jacksonville, FL 32224, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Mayo Clinic Jacksonville a $874,988 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to characterize TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in women. The grant will support research from June 2022 to June 2026 aimed at transforming military and public health through innovative medical solutions for the battlefield and investigating solutions to prevent heart damage from chemotherapy. As the prime awardee, Mayo Clinic Jacksonville will lead the research effort to develop methods to predict and prevent heart issues in women undergoing chemotherapy through studying the role of TRPC6, with the goal of improving health outcomes for service members and the general public.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Florida | $51,505 | |
| University Of Florida | $50,125 |
Quick answers
Who received award W81XWH2210289?
W81XWH2210289 was awarded to Mayo Clinic Jacksonville (A Nonprofit Corporation) by Medical Command (Department of the Army) on June 15, 2022.
How much is award W81XWH2210289 worth?
$874,988 has been obligated on W81XWH2210289.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award